99% pqq(ピロロキノリンキノン)バルク粉末

pqq粉末とは何ですか?

pqq,別名pyrroloquinoline quinone, 4,5-dihydro-4,5- dioxo-1h-pyrrolo [2,3-f] quinoline-2,7,9-tricarboxylic acid,分子式c14h6n2o8,分子量330.206。

自然界におけるpqqの最初の起源は、グルタミン酸とチロシンを基質としたグラム陰性細菌によって合成されたと考えられている。植物組織中のpqqは、根間微生物による生合成に由来し、食物連鎖を通じて動物に侵入する。微生物または化学合成によるピロキノリンキノンの生産は工業化されている。

pqq (pyrroloquinoline quinone)は、ミトコンドリアの成長と発達をサポートし、ヒト細胞の急速な成長を刺激し、フリーラジカルを除去し、細胞の損傷を減少させる強力な抗酸化特性を持っています。心臓血管の健康、脳の健康、代謝機能の健康などに強力な役割を持っています。それは主に物理的な回復と抗疲労を助けることができます。

グリーンスプリング技術は99% pqq (pyrroloquinoline quinone)バルク粉末、安定性、高含有量、微細粉末、良好な溶解性、無農薬残留物、および低溶剤残留物を提供しています。グリーンスプリングはhalal、kosher、cosmos、brc、ifs、fda、isoなど多くの認証を取得しています。グリーンスプリングは、常にお客様に自然、安全、有機植物抽出物を提供することに取り組んできました。当社が提供するすべての製品は、最高の国際的な業界標準に準拠して実装されています。権威あるサードパーティのテストレポートが利用可能です。

规格:

規制:

euの規制に準拠しています。

Benefits:

Growth Promoting Factors

Poor mitochondrial physical and mental health is associated with a variety of common diseases, including IQ decline, heart disease, diabetics and cancer. Controlled studies in mice fed with PQQ have shown that PQQ powder not only promotes mitochondrial growth, but also prolongs the life of the active components of mitochondrial biosynthesis, avoids oxidation of vital air, and enhances energy utilization. However, in tissue cell experiments, pyrroloquinoline quinone powder was able to stimulate human fibroblast DNA production, copying and cellular metabolism when PQQ concentration values were relatively low.

Researchers have analyzed that improving mitochondrial physical and mental health is likely to be the reason behind many of PQQ's physical and mental health benefits, such as improved kinetic energy, memory and sleep quality.

Neuroprotection

In an experiment analyzing the association between pyrroloquinoline quinone powder and stroke and cervical cord injury, it was found that PQQ powder could reduce neuronal death, and at the same time effectively promote the functional recovery of rat spinal nerves after hemisection injury.PQQ significantly reversed the reduction of Bax/Bcl-2 caused by β-amyloid convergence and suppressed the cleavage of Caspase-3. Pyrroloquinoline quinone powder suppressed the establishment of amyloid and its cytotoxicity of shortened α-synuclein and maintained neuronal cells damaged by the toxic side effects of β-amyloid convergence. PQQ powder inhibits the establishment of amyloid and the cytotoxicity of shortened α-synuclein, and maintains neuronal cells damaged by the toxic side effects of β-amyloid aggregation.

An exploration of 41 Japanese older adults tested the autonomic impact of PQQ. Over 12 weeks of days, study subjects were split into 2 groups, each taking 20mg of PQQ or a placebo effect. Cognitive tests illustrated that pyrroloquinoline quinone powder boosted memory and concentration, and brain scans uncovered elevated blood volume.

Antioxidant

The antioxidant effect of pyrroloquinoline quinone(PQQ) powder could be significantly noticed in the test of PQQ poultry and livestock. It was found that PQQ can inhibit the establishment of sodium peroxynitrite, block SIN-1-induced ATP deprivation, and eliminate superoxide anion to prevent the nitration reaction of bovine serum albumin. In addition, PQQ blocked the neurotoxin 6-methylcholine from causing ozone and reduced the cytotoxicity of 6-methyldopamine.

Applications:

For Health Products:

Pyrroloquinoline quinone (PQQ) powder can be used as a therapeutic aid in heart disease, neurological disorders, liver protection, etc. The nutritional and efficacy value of PQQ  has been recognized and it has become a popular mitochondrial supplement in foreign countries. PQQ has been widely used in brain health, energy supplementation, cardiovascular health, beauty and many other areas.PQQ powder is not only used alone but also combined with traditional mitochondrial supplements such as Coenzyme Q10, Lipoic Acid, Taurine, L-Carnitine, and so on.

In the Food Field:

In recent years, as awareness continues to grow, PQQ has achieved the most comprehensive efficacy certification and has been classified as a high safety dietary supplement in the United States and the European Union.

United States: Pyrroloquinoline quinone (PQQ) has obtained GRAS certification from the U.S. Food and Drug Administration (FDA), and can be used as an ingredient in food products such as energy drinks, sports drinks, electrolyte drinks, and bottled water; in 2009, the first PQQ dietary supplement was approved in the United States for the first time, and the supplement ingredient is the sodium salt of PQQ (PQQ-2Na+) since PQQ is slightly soluble in water.

EU: On 13 August 2018, the European Commission (ESFA) published Regulation (EU) 2018/1122 approving pyrroloquinoline quinone sodium salt as a novel food. Following Regulation (EU) 2015/2283 of the European Parliament and of the Council, the Commission amended the Annex to Implementing Regulation (EU) 2017/2470 for the use of pyrroloquinoline quinone sodium salt as a dietary supplement as defined in Directive 2002/46/EC for the target population of adults excluding pregnant and breastfeeding women, with a maximum dosage of pyrroloquinoline quinone sodium salt of 20mg/day.